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Abstract
Background: Growing concerns regarding the adverse effects of antibiotics during the first days of life and the
marked reduction in the incidence of early-onset sepsis (EOS) are changing the clinical practice for managing
neonates at risk of EOS. Strategies avoiding unnecessary antibiotics while promoting mother-infant bonding and
breastfeeding deserve to be considered.
Main body: We compare strategies for managing newborns at risk of EOS recommended by the American
Academy of Pediatrics, which are among the most followed recommendations worldwide. Currently three different
approaches are suggested in asymptomatic full-term or late preterm neonates: i) the conventional management,
based on standard perinatal risk factors for EOS alone, ii) the neonatal sepsis calculator, a multivariate risk
assessment based on individualized, quantitative risk estimates (relying on maternal risk factors for EOS) combined
with physical examination findings at birth and in the following hours and iii) an approach entirely based on
newborn clinical condition (serial clinical observation) during the first 48 h of life.
We discuss advantages and limitations of these approaches, by analyzing studies supporting each strategy.
Approximately 40% of infants who develop EOS cannot be identified on the basis of maternal RFs or laboratory
tests, therefore close monitoring of the asymptomatic but at-risk infant remains crucial. A key question is to know
what proportion of babies with mild, unspecific symptoms at birth can be managed safely without giving
antibiotics.
Conclusions: Both neonatal sepsis calculator and serial clinical observation may miss cases of EOS, and clinical
vigilance for all neonates is essential There is a need to assess which symptoms at birth are more predictive of EOS,
and therefore require immediate interventions, or symptoms that can be carefully reevaluated without necessarily
treat immediately the neonate with antibiotics. Studies comparing strategies for managing neonates are
recommended.
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Background
Early onset sepsis (EOS) is sepsis presenting from 0 to
72 h of life [1, 2]. Although its current incidence is lower
than in the past [3], EOS is still a problem. Non-specific
clinical presentation and low predictive values of com-
mon biomarkers complicate the early diagnosis [2], that
is essential to prevent life threatening complications. An-
tibiotics are often given in suspected EOS, but unneces-
sary antibiotics have potential adverse consequences [4,




Standard perinatal RFs alone are insufficient for ascer-
tainment of neonatal EOS. Indeed, current diagnostic
tests are poorly predictive of EOS in asymptomatic neo-
nates, resulting in unnecessary evaluations and antibiotic
exposure for numerous uninfected neonates [2]. In fact,
up to 15% of infants are evaluated for EOS, and approxi-
mately half of them receive empiric antibiotic treatment
for rule out EOS [6].
The neonatal sepsis calculator (NSC)
A multivariate risk assessment has been developed by
Kaiser Permanent Northern California (CA, USA). Indi-
vidualized, quantitative risk estimates (based on maternal
RFs) are combined with physical examination findings.
According to perinatal information such as gestational
age, duration of membrane rupture, highest maternal
temperature during labour, GBS colonization status, intra-
partum antibiotic prophylaxis (IAP) and clinical condi-
tions in the first 12 h of life (well appearing, equivocal, or
clinically ill, Table 1) a sepsis risk score was developed [8].
The RFs based logistic regression model was developed
by using a nested case-control study performed at 14 US
centers. This large study included data from 608,014 ne-
onates with ≥34 weeks’ gestation born in the period be-
tween 1993 and 2007 [9]. Cases of EOS (n = 350) were
defined as isolation of a pathogen (or a contaminant
treated with antibiotics for at least 5 days) in blood or
CSF culture within 72 h of birth, regardless of the pres-
ence of symptoms. Furthermore, investigators randomly
selected 1063 controls from the birth cohort, and each
case of EOS was matched with three controls. The most
predictive factors for EOS were lower gestational age
and higher intrapartum maternal temperature, which
accounted for 17 and 58% of the model’s predictive abil-
ity, respectively. However, 32% of neonates in the initial
cohort with positive blood cultures were asymptomatic,
a finding that may potentially overestimate the risk of
EOS in the regression model. NSC was updated in 2014
[10] to incorporate into the risk stratification algorithm
the results of physical examination (well appearing,
equivocal presentation and clinical illness) until the first
24 h of life. For each category of disease, likelihood ratios
were identified which, when combined with the risk of
sepsis at birth (based on RFs alone), generated a post-
test probability of EOS by dividing newborns into 3 risk
layers (< 0.65, 0.65–1.54 and > 1.54 cases/1000 live
births, respectively). The clinical presentation had effects
on the posterior probability for a given EOS risk at birth
(likelihood ratio 0.41, 5.0 and 21.2 for well appearing,
equivocal and clinical illness, respectively). For each in-
fant the NSC estimated the individual risk of EOS. A
posterior risk of EOS < 1, 1–3 and > 3/1000 live births
indicated different recommendations (observation,
evaluation or antibiotic treatment) [11].
Table 1 Classification of Infant’s Clinical Presentation according to NSC (available at https://neonatalsepsiscalculator.
kaiserpermanente.org/) [7]
Clinical Exam Description
Clinical Illness 1. Persistent need for NCPAP / HFNC / mechanical ventilation (outside of the delivery room)
2. Hemodynamic instability requiring vasoactive drugs
3. Neonatal encephalopathy /Perinatal depression
▪ Seizure
▪ Apgar Score at 5 min < 5
4. Need for supplemental O2 > 2 h to maintain oxygen saturations > 90% (outside of the delivery room)
Equivocal 1. Persistent physiologic abnormality > 4 h
▪ Tachycardia (HR > 160)
▪ Tachypnea (RR > 60)
▪ Temperature instability (> 100.4 °F or < 97.5 °F)
▪ Respiratory distress (grunting, flaring, or retracting) not requiring supplemental O2
2. Two or more physiologic abnormalities lasting for > 2 h
▪ Tachycardia (HR > 160)
▪ Tachypnea (RR > 60)
▪ Temperature instability (> 100.4 °F or < 97.5 °F)
▪ Respiratory distress (grunting, flaring, or retracting) not requiring supplemental O2
Note: abnormality can be intermittent
Well Appearing No persistent physiologic abnormalities
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However, in the determination of the final risk, the de-
velopers of the model attributed an a priori greater rele-
vance to symptoms, although in absence of strong
evidences [12]. Symptoms defined as “equivocal” or
“clinical illness” are common in the first hours of life,
due to transition to extrauterine life. Developers of NSC
introduced safeguards to not discontinue (“strongly con-
sider”) antibiotics in infants with clinical symptoms, even
if the posterior probability was below the threshold for
treatment (< 3 cases/1000 live births) [11]. This recom-
mendation would increase antibiotic exposure in unin-
fected infants [12].
Comparisons between NSC and CM
A systematic review and meta-analysis of published
before–after studies regarding NSC [13] included 13
relevant studies and analyzed a total of 175,752 in-
fants. With respect to CM guided strategies, NSC was
associated with a reduction in empiric antibiotic use
for suspected EOS [relative risk of antibiotic use of
56, 95% C.I. 53–59%]. Rates of missed cases of EOS
(defined as an antibiotic initiated after 24 h of life in
neonates with culture-positive EOS) were comparable
(NSC: 28% vs. CM: 29%, pooled odds ratio, 0.96; 95%
C.I., 0.26–3.52; P = 0.95). However, NSC does not
provide accurate risk estimates with regard to abso-
lute risk of EOS in newborn babies. Estimates might
be compromised by technical issues arising with the
development and adaptation of the NSC prediction al-
gorithm [12].
Serial clinical observation (SCO)
An approach entirely based on newborn clinical condi-
tion during the first hours of life has recently gained
consensus [14, 15]. Asymptomatic neonates undergo a
standardized observation (by midwives, nurses and phy-
sicians) in the first 48 h of life (Table 2). Laboratory
evaluation or empirical antibiotic treatment are only ini-
tiated if clinical signs of illness develop [16].
A retrospective cohort study at a single Italian centre
(20,401 live births from 2005 to 2011) [14] compared a
random sample of 500 neonates managed according to
CM and 500 neonates managed through SCO. Investiga-
tors reported significant reduction of laboratory tests
(from 11.6 to 1.6%, P < 0.01) and empirical antibiotics
(from 2.8 to 0.6%, P < 0.01) following an SCO approach.
By reviewing cases of EOS occurring in both periods in-
vestigators found no evidence of delayed antibiotic ad-
ministration or increased risk of neonates to be
readmitted for EOS after discharge from hospital. How-
ever, the initial symptoms triggering laboratory evalu-
ation or antibiotic therapy were poorly standardized in
the original SCO approach, and there was heterogeneity
among centers in the timing and ways of performing
SCO. This strategy has been recently updated [16, 17].
Minor and major clinical symptoms and criteria most
suggestive of EOS during the first hours of life have been
recently defined (Table 3).
SCO recommends observation (without empirical anti-
biotics) for most neonates with mild, nonspecific symp-
toms (even in the presence of RFs). Such symptoms are
quite different from those suggested by the NSC. Thus,
Table 2 Serial clinical observation approach recommended in Emilia-Romagna (Italy) (modified with permission from ref. [16]).
Clinical observation record sheet and timing of visits
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the use of empirical antibiotics is likely to be different.
The safety of this updated SCO strategy is under
evaluation.
As with the NSC strategy, cases of EOS may be missed
with SCO if neonates are selected only on the basis of
maternal RFs. A large, multicenter study in Italy re-
ported 48 cases of confirmed group B streptococcus
EOS among 265,508 live births managed through an
SCO approach; 15 of 48 cases (31.2%) had no RFs for
EOS and had symptoms of EOS (three had severe dis-
ease) during their hospitalization. Most of them (n = 12)
were well appearing at birth but subsequently developed
symptoms [18].
Comparisons between NSC and SCO
A retrospective study [19] addressed both safety and em-
piric antibiotic use for suspected EOS after an SCO or
NSC guided approach. Investigators analyzed a cohort of
384 infants of gestational age ≥ 34 weeks undergoing
antibiotic therapy in the first 72 h of life. While no cases
of EOS would have been missed with both strategies,
newborns who would have received antibiotics according
to SCO or NSC were 17 and 57% (p < 0.001) respect-
ively. However, the selection of neonates for antibiotic
treatment was decided a posteriori, after the newborns
had already been managed by the clinician.
Conclusions
Both NSC and SCO may miss cases of EOS, and clinical
vigilance for all neonates is essential. Furthermore, un-
necessary antibiotics would be reduced by identifying
symptoms more predictive of EOS. Studies comparing
strategies for managing neonates are recommended.
Abbreviations
EOS: Early-onset sepsis; RFs: Risk factors; NSC: Neonatal sepsis calculator;




Prof. Alberto Berardi has not received fees.
Authors’ contributions
AB, EV and AL drafted the initial manuscript, reviewed, revised, and approved
the final manuscript as submitted. AB and EV designed the data collection
instruments, drafted the initial manuscript, reviewed, revised, and approved
the final manuscript as submitted. They conceptualized and designed the
study, critically reviewed the manuscript, and approved the final manuscript
as submitted. All authors approved the final manuscript as submitted and
agree to be accountable for all aspects of the work.
Availability of data and materials
Not applicable.
Declarations
Ethics approval and consent to participate




The authors declare that they have no competing interests.
The authors declare they have no funding source.
Author details
1Post Graduate School of Paediatrics, Department of Medical and Surgical
Sciences of the Mothers, Children and Adults, University of Modena and
Reggio Emilia, via del Pozzo 71, 41124 Modena, Italy. 2Neonatal Intensive
Care Unit, Department of Medical and Surgical Sciences of the Mothers,
Children and Adults, University of Modena and Reggio Emilia, via del Pozzo
71, 41124 Modena, Italy. 3Pediatric Unit, Department of Medical and Surgical
Sciences of the Mothers, Children and Adults, University of Modena and
Reggio Emilia, via del Pozzo 71, 41124 Modena, Italy.
Received: 25 January 2021 Accepted: 15 June 2021
References
1. Puopolo KM, Benitz WE, Zaoutis TE, Committee on fetus and newborn,
Committee on Infectious Diseases. Management of Neonates Born at ≥35
0/7 weeks’ gestation with suspected or proven early-onset bacterial Sepsis.
Pediatrics. 2018;142(6):e20182894. https://doi.org/10.1542/peds.2018-2894.
Table 3 Minor and major clinical symptoms and criteria suggesting observation or laboratory evaluation and antibiotic treatment
Minor ‡ Major
Mild respiratory distress (> 60 bpm) without the need of
respiratory support
Moderate to severe respiratory distress (requiring respiratory support) §→ tachypnoea
plus increased respiratory effort
Tachycardia > 160 bpm Hypoxia, reduced SpO2 saturation
Metabolic acidosis (base excess ≤ − 10 mmol/lt) Reduced skin perfusion, Refill time ≥ 3 “
Signs of shock
Temperature < 36° or > 37.5 < 38 °C Temperature≥ 38 °C
Greyish, pallor or marbling of the skin colour
Worsening of general wellbeing, apnoea, lethargy, irritability, convulsions
SpO2, Saturation of peripheral oxygen
‡ On the basis of the clinician’s judgment laboratory evaluation can be delayed in the presence of minor, initial, unspecific and non-progressive symptoms during
the first 12–24 h of life. Neonates with mild symptoms are re-evaluated at 2-h intervals. The presence of major symptoms, the worsening or persistence (for 12–
24 h) of minor symptoms suggest laboratory evaluation and (eventually) empirical antibiotics, but the decision is left to the clinician’s discretion
§ respiratory support includes mechanical ventilation and nasal continuous positive airway pressure. However, it does not necessarily include high flow
nasal cannula
Vaccina et al. Italian Journal of Pediatrics          (2021) 47:159 Page 4 of 5
2. Benitz WE, Wynn JL, Polin RA. Reappraisal of guidelines for Management of
Neonates with suspected early-onset Sepsis. J Pediatr. 2015;166(4):1070–4.
https://doi.org/10.1016/j.jpeds.2014.12.023.
3. Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, et al. A
quantitative, risk-based approach to the management of neonatal early-
onset Sepsis. JAMA Pediatr. 2017;171(4):365–71. https://doi.org/10.1001/jama
pediatrics.2016.4678.
4. Ficara M, Pietrella E, Spada C, Della Casa Muttini E, Lucaccioni L, Iughetti L,
et al. Changes of intestinal microbiota in early life. J Matern Fetal Neonatal
Med. 2020;33(6):1036–43. https://doi.org/10.1080/14767058.2018.1506760.
5. Benitz WE, Long SS. The holy grail of ascertainment of early-onset neonatal
Sepsis. J Pediatr. 2019;213:10–2. https://doi.org/10.1016/j.jpeds.2019.05.072.
6. Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis
evaluations among well-appearing infants: projected impact of changes in
CDC GBS guidelines. J Perinatol. 2013;33(3):198–205. https://doi.org/10.1038/
jp.2012.96.
7. Kaiser Permanente Division of Research. Neonatal Early-Onset Sepsis
Calculator. 2021. Available from: https://neonatalsepsiscalculator.kaiserperma
nente.org/
8. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, et al.
Estimating the probability of neonatal early-onset infection on the basis of
maternal risk factors. Pediatrics. 2011;128(5):e1155–63. https://doi.org/10.1
542/peds.2010-3464.
9. Puopolo KM, Escobar GJ. Early-onset sepsis: a predictive model based on
maternal risk factors. Curr Opin Pediatr. 2013;25(2):161–6. https://doi.org/10.1
097/MOP.0b013e32835e1f96.
10. Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, et al.
Stratification of risk of early-onset Sepsis in newborns ≥34 weeks’ gestation.
Pediatrics. 2014;133(1):30–6. https://doi.org/10.1542/peds.2013-1689.
11. Kuzniewicz MW, Walsh EM, Li S, Fischer A, Escobar GJ. Development and
implementation of an early-onset Sepsis calculator to guide antibiotic
Management in Late Preterm and Term Neonates. Jt Comm J Qual Patient
Saf. 2016;42(5):232–9. https://doi.org/10.1016/S1553-7250(16)42030-1.
12. Benitz WE, Achten NB. Technical assessment of the neonatal early-onset
sepsis risk calculator. Lancet Infect Dis. 2020:S1473309920304904.
13. Achten NB, Klingenberg C, Benitz WE, Stocker M, Schlapbach LJ, Giannoni E,
et al. Association of Use of the Neonatal Early-Onset Sepsis Calculator With
Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-
analysis. JAMA Pediatr. 2019;173(11):1032.
14. Joshi NS, Gupta A, Allan JM, Cohen RS, Aby JL, Weldon B, et al. Clinical
monitoring of well-appearing infants born to mothers with
Chorioamnionitis. Pediatrics. 2018;141(4):e20172056. https://doi.org/10.1542/
peds.2017-2056.
15. Berardi A, Fornaciari S, Rossi C, Patianna V, Bacchi Reggiani ML, Ferrari F, et al.
Safety of physical examination alone for managing well-appearing neonates
≥35 weeks’ gestation at risk for early-onset sepsis. J Matern Fetal Neonatal
Med. 2015;28(10):1123–7. https://doi.org/10.3109/14767058.2014.946499.
16. Berardi A, Bedetti L, Spada C, Lucaccioni L, Frymoyer A. Serial clinical
observation for management of newborns at risk of early-onset sepsis. Curr
Opin Pediatr. 2020;32(2):245–51. https://doi.org/10.1097/MOP.
0000000000000864.
17. Berardi A, Spada C, Ciccia M, et al. Observation of the newborn at risk of
early-onset sepsis: the approach of the region Emilia-Romagna (Italy).
Medico e Bambino. 2019;38:370–6.
18. Berardi A, Spada C, Reggiani MLB, Creti R, Baroni L, Capretti MG, et al. Group
B Streptococcus early-onset disease and observation of well-appearing
newborns. Simeoni U, editor. PLoS ONE. 2019;14(3):e0212784.
19. Benincasa BC, Silveira RC, Schlatter RP, Balbinotto Neto G, Procianoy RS.
Multivariate risk and clinical signs evaluations for early-onset sepsis on late
preterm and term newborns and their economic impact. Eur J Pediatr.
2020;179(12):1859–65. https://doi.org/10.1007/s00431-020-03727-z.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Vaccina et al. Italian Journal of Pediatrics          (2021) 47:159 Page 5 of 5
